Market
Overview
The Neurorehabilitation
Devices Market Size exhibiting
a compound annual growth rate (CAGR) of 7.90% during the forecast period (2023
- 2032). Neurological rehabilitation is a treatment program overseen by a team
of specialists for patients suffering from sickness, injury, or malfunction of
the neurological system. Neurorehabilitation devices are used in the field of
physiotherapy to aid in the learning of motor abilities. Neurorobotic systems,
non-invasive brain stimulators, brain-computer interfaces, and wearable devices
are all examples of neurorehabilitation equipment. With the use of these
technologies, rehabilitation products have advanced and improved in terms of
intensity and quality. It has ensured that neurorehabilitation equipment
provides the best and most important results in neurological illnesses.
Competitive
Landscape
The Neurorehabilitation
Devices Market players in the market are :
·
Abbott
Laboratories,
·
Ekso Bionics
Holdings Inc,
·
Helius
Medical Technologies,
·
Hocoma AG,
·
Medtronic Inc,
·
Others
Following the pandemic, a
developing culture of entrepreneurs, and neuroscientists, the
Neurorehabilitation Devices Market is now open to a variety of people who wish
to make money. Those who have invested in the Neurorehabilitation Devices
Market have contributed to the advancement of this culture and market trends.
In reality, patients are now consulting remotely for each of their application
parts. As a result, it has provided a landscape for the neurorehabilitation
device industry, as well as the possibility to interact with diverse persons to
move the market forward. Parkinson's disease and stroke are the diseases with
the highest CAGR in terms of application category in the coming years.
Market
Segmentation
Based on the Type, the global Neurorehabilitation
Devices Market insights has been segmented into Neuro-Robotic Devices,
Wearable Devices, Non-Invasive Stimulators, Brain-Computer, and Interface
(BCIs).
Based on the Application, the
global Neurorehabilitation Devices Market has been segmented into Brain stroke,
Parkinson's Disease, Multiple sclerosis, Spinal cord injury, Cerebral palsy,
Schizophrenia, etc.
Based on the End-User, the global
Neurorehabilitation Devices Market has been segmented into Hospitals/Clinics
and Cognitive Care Centers.
Based on the Region, the global
Neurorehabilitation Devices Market has been segmented into North America,
Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Regional
Classification
North America dominates the
worldwide market with the United States and Canada. The regional market has
grown as the occurrences of Alzheimer's and Parkinson's disease has increased,
leading to an increase in government financing through particular Senate of
Canada programs. Europe consists of the UK, Germany, Italy, France, Belgium,
Russia, Poland, and the rest of Europe. The Asia-Pacific includes India,
Australia, New Zealand, China, South Korea, Japan, Thailand, Indonesia, and
Vietnam, as well as the rest of the continent. The market for
neurorehabilitation equipment is predicted to expand gradually. The
architecture of medicine is changing, and it is expected that healthcare
infrastructure and neurological devices will develop during the forecast
period. According to statistics, market growth in areas where the majority of
the population is over 60 years old ranges from 8.1 percent to 8.5 percent
every year.
Industry News
The major key players in the
Neurorehabilitation Devices Market are Abbott Laboratories, Ekso Bionics
Holdings Inc., Helius Medical Technologies, Hocoma AG, Medtronic Inc., and
Others. Government support has begun, and countries such as Africa are now contributing
products on a philanthropic basis.
About US:
Market Research Future (MRFR)
enable customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New
York,
New York 10013
